ANGI is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some upside narrative around an AI platform shift and EBITDA improvement, but the price trend is still weak, analyst targets have been cut sharply, and the latest quarter showed declining revenue and worsening net income. For an impatient investor, this is not a clean long-term entry today.
The technical setup is bearish. MACD histogram is below zero and deteriorating, moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5, and price is sitting near support at 5.172, only slightly below the current 5.25 level. RSI_6 at 26.243 suggests the stock is oversold, but not yet showing a confirmed reversal. The short-term pattern data also points to weak follow-through, with negative expected returns over the next day, week, and month.

["Management is pushing an AI-native platform strategy, which could improve long-term positioning.", "Q1 EBITDA of $23 million beat expectations.", "News suggests proprietary revenue is gaining momentum.", "Gross margin remains very high at 89.76%."]
["Q1 revenue fell 3.16% YoY to $238.15 million.", "Net income fell sharply to -$8.98 million and EPS was -$0.22.", "User engagement declined, raising concern about core demand trends.", "Several analysts cut price targets materially after Q1.", "KeyBanc downgraded the stock and said visibility into a revenue recovery is diminished.", "No AI Stock Picker signal and no SwingMax signal today.", "No recent congress trading data and no notable politician/influencer buying support."]
In Q1 2026, Angi reported revenue of $238.15 million, down 3.16% year over year, with net income falling to -$8.98 million and EPS dropping to -$0.22. Gross margin remained strong at 89.76%, and EBITDA was reported at $23 million, which beat expectations. However, the key top-line trend is still negative, and the quarter showed weaker engagement and operating losses, which makes the growth picture unconvincing for a long-term beginner investor.
Recent analyst sentiment has turned more cautious. RBC cut its target to $5 and keeps Sector Perform, JPMorgan cut to $5 and stays Neutral, Goldman lowered to $10 and stays Neutral, and KeyBanc downgraded to Sector Weight. Truist and Benchmark remain bullish with Buy ratings, but both cut targets substantially. Overall, Wall Street is split, but the tone has clearly shifted more negative after Q1, with reduced confidence in near-term revenue growth and profitability visibility. No significant politician or influencer trading was reported, and there is no recent congress trading activity.